179
Participants
Start Date
November 17, 2023
Primary Completion Date
January 22, 2025
Study Completion Date
July 9, 2025
LY3305677
Administered SC
Placebo
Administered SC
North Suffolk Neurology, Port Jefferson Station
Dent Neurologic Institute, Amherst
Spectrum Medical, Inc., Danville
Lucas Research, Inc., New Bern
Northeast Research Institute (NERI), Fleming Island
Charter Research - Lady Lake, The Villages
Charter Research - Winter Park, Orlando
Suncoast Clinical Research, Inc., New Port Richey
Quality Medical Research, Nashville
L-MARC Research Center, Louisville
CTI Clinical Research Center, Cincinnati
Great Lakes Clinical Trials - Andersonville, Chicago
Great Lakes Clinical Trials - Ravenswood, Chicago
StudyMetrix Research, City of Saint Peters
Cotton O'Neil Diabetes & Endocrinology, Topeka
Velocity Clinical Research, Dallas, Dallas
PlanIt Research, PLLC, Houston
Tekton Research - Fredericksburg Road, San Antonio
IMA Clinical Research Austin, Austin
The Institute for Liver Health II dba Arizona Clinical Trials - Mesa, Chandler
Headlands Research - Scottsdale, Scottsdale
The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
Las Vegas Medical Research, Las Vegas
Velocity Clinical Research, Huntington Park, Huntington Park
Peninsula Research Associates, Rolling Hills Estates
Diablo Clinical Research, Inc., Walnut Creek
Pacific Diabetes & Endocrine Center, Honolulu
Central Washington Health Services Association d/b/a Confluence Health, Wenatchee
Knownwell, Needham
Eli Lilly and Company
INDUSTRY